Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: ACTELION PHARMACEUTICALS US, INC.
Awarding agency: Department of Justice / Federal Prison System / Bureau of Prisons
Funding agency: Department of Justice / Federal Prison System / Bureau of Prisons
Period of performance: 2025-06-01 to 2025-06-30
Current total value of award: $12540.07
Description: FY25 B1 CURASCRIPT TYVASO/OPSUMIT MEDS JUN25